Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sanyal

Showing results (41-50 of 686) with videos related to

Pageof 69
Sort By:
Current Pharmaceutical Design|April 8, 2010
Role of microRNAs in non-alcoholic steatohepatitisOnpan Cheung, Arun J Sanyal
Postgraduate Medicine|March 29, 2001
Minimizing ascites. Complication of cirrhosis signals clinical deteriorationN Garcia, A J Sanyal
Current Hepatology Reports|August 6, 2019
Pathogenesis of NASH: The Impact of Multiple PathwaysMazen Noureddin, Arun J Sanyal
Seminars in Liver Disease|December 18, 2004
Clinical aspects of fatty liver diseaseJayanta Choudhury, Arun J Sanyal
Clinics in Liver Disease|August 28, 2004
Insulin resistance and the pathogenesis of nonalcoholic fatty liver diseaseJayanta Choudhury, Arun J Sanyal
Clinics in Liver Disease|October 9, 2013
Drug-induced steatohepatitisVaishali Patel, Arun J Sanyal
Pharmaceutical Medicine|January 15, 2020
Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to DateSomaya Albhaisi, Arun J Sanyal
Current Opinion in Gastroenterology|February 20, 2010
Recent advances in nonalcoholic fatty liver diseaseOnpan Cheung, Arun J Sanyal
Current Opinion in Clinical Nutrition and Metabolic Care|October 19, 2012
Vitamin E and nonalcoholic fatty liver diseaseTommy Pacana, Arun J Sanyal
Gastroenterology Clinics of North America|December 3, 2014
Nonendoscopic management strategies for acute esophagogastric variceal bleedingSanjaya K Satapathy, Arun J Sanyal
Pageof 69

Showing results (41-50 of 686) with videos related to

Sort By:
Pageof 69
Current Pharmaceutical Design|April 8, 2010
Role of microRNAs in non-alcoholic steatohepatitisOnpan Cheung, Arun J Sanyal
Postgraduate Medicine|March 29, 2001
Minimizing ascites. Complication of cirrhosis signals clinical deteriorationN Garcia, A J Sanyal
Current Hepatology Reports|August 6, 2019
Pathogenesis of NASH: The Impact of Multiple PathwaysMazen Noureddin, Arun J Sanyal
Seminars in Liver Disease|December 18, 2004
Clinical aspects of fatty liver diseaseJayanta Choudhury, Arun J Sanyal
Clinics in Liver Disease|August 28, 2004
Insulin resistance and the pathogenesis of nonalcoholic fatty liver diseaseJayanta Choudhury, Arun J Sanyal
Clinics in Liver Disease|October 9, 2013
Drug-induced steatohepatitisVaishali Patel, Arun J Sanyal
Pharmaceutical Medicine|January 15, 2020
Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to DateSomaya Albhaisi, Arun J Sanyal
Current Opinion in Gastroenterology|February 20, 2010
Recent advances in nonalcoholic fatty liver diseaseOnpan Cheung, Arun J Sanyal
Current Opinion in Clinical Nutrition and Metabolic Care|October 19, 2012
Vitamin E and nonalcoholic fatty liver diseaseTommy Pacana, Arun J Sanyal
Gastroenterology Clinics of North America|December 3, 2014
Nonendoscopic management strategies for acute esophagogastric variceal bleedingSanjaya K Satapathy, Arun J Sanyal
Pageof 69